Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint
Basel, Switzerland (ots/PRNewswire) - - Results of This Trial Further Confirm the Benefit Avastin Brings to Patients With Breast Cancer. Roche announced today that a phase III study in metastatic breast cancer investigating Avastin (bevacizumab) in combination with docetaxel chemotherapy compared to docetaxel alone, met its primary endpoint of improving the ...